重症患者のセフタジドーム-アビバクタム: 多センター観察研究
Olivieri Silvia1, Sara Mazzanti2, Gabriele Gelo Signorino2,3
1Infectious Diseases, Via Murri, 15, 63023 Fermo, Italy.
Antibiotics (Basel, Switzerland)
|August 28, 2025
まとめ
Ceftazidime- avibactam (CAZ- AVI) は,重症患者で中程度の有効性を示し,58%の陽性結果率を示しています. しかし,急速な耐性開発は,集中治療室でのCAZ-AVIの使用を最適化するために,注意深い抗菌管理を必要とします.
科学分野:
- 感染症
- クリティカル ケア 医療
- 薬理学について
背景:
- セファチジム- アビバクタム (CAZ- AVI) は,グラム陰性細菌感染症の重要な静脈内投与抗生物質である.
- 重症患者集団におけるCAZ- AVIの有効性と安全性に関するデータは限られている.
- この研究は,集中治療室 (ICU) の環境におけるさらなる証拠の必要性に対処しています.
研究 の 目的:
- CAZ- AVIで治療された重症患者の30日間の臨床結果を評価する.
- 死亡と再発を含む30日間の臨床失敗に関連する危険因子を特定する.
- ICUコホートにおけるCAZ- AVIの有効性と安全性を評価する.
主な方法:
- 4つのICUで多センター,遡及,観察コホート研究が行われました.
- 少なくとも72時間CAZ- AVIを投与した重症成人患者161人を対象とした.
- 患者は,確認されたまたは疑われたグラム陰性細菌感染のために治療を受けました.
主要な成果:
- CAZ- AVIは患者の58%で陽性な臨床結果を達成し,全死亡率は24%であった.
- 25% の患者で再発または持続的な感染が発生し,26% が獲得抵抗性を発症しました.
- 免疫抑制症の患者,特に肝臓移植を受けた患者では,治療失敗率が高かった.
結論:
- 集中治療室でのCAZ- AVI死亡率は,他の研究と比較できます.
- CAZ-AVI耐性の急速な出現は 抗生物質管理の必要性を強調しています
- 薬物動力学/ 薬物動力学 (PK/ PD) の最適化は,重症患者におけるCAZ- AVIの有効な使用に不可欠です.
さらに関連する動画
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
7.1K
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
1.2K
関連する概念動画
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:17Urinary Tract Infection IV: Nursing Management
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...